Last reviewed · How we verify
NCT06316583
Clinical Study on Dry Needling for Primary Dysmenorrhea and Its Preliminary Correlation With Acupoints
NA trial testing TrP-DN and Acupuncture in Trigger Point Pain, Myofascial in 150 participants. Currently enrolling.
31 December 2025
Quick facts
| Lead sponsor | Beijing Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 150 |
| Start date | 1 April 2024 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 December 2026 |
| Sites | 2 locations across China |
Drugs / interventions tested
- TrP-DN and Acupuncture
Conditions studied
- Trigger Point Pain, Myofascial — all drugs for Trigger Point Pain, Myofascial →
- Acupuncture — all drugs for Acupuncture →
- Primary Dysmenorrhea — all drugs for Primary Dysmenorrhea →
Sponsor
Beijing Hospital
Who can join
Adults 18 to 30, female only, with Trigger Point Pain, Myofascial or Acupuncture. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Primary dysmenorrhea refers to menstrual pain not caused by pelvic organic lesions, commonly seen in young women, significantly affecting patients' quality of life. Dry needling therapy targeting myofascial trigger points for primary dysmenorrhea has been preliminarily applied in clinical settings. However, related research is limited with questionable quality, hindering its widespread clinical application. Furthermore, is there a connection between myofascial trigger points in dry needling and acupuncture acupoints in terms of selection and mechanism of action? Could this be a new interpretation of acupuncture theory? These are important questions that have garnered widespread attention. This study employs a randomized patient-blinded controlled design, enrolling primary dysmenorrhea patients aged 18 to 30 years. They are randomly divided into three groups: the trigger point dry needling group, traditional acupuncture treatment group, and trigger point sham needle (placebo) group. Changes in pain levels, quality of life scores, inflammatory factor levels, and local blood flow before and after treatment among the three groups are observed. The aim is to assess the therapeutic effects of dry needling trigger points and acupuncture treatments on primary dysmenorrhea and explore their potential mechanisms of action. By comparing the differences and similarities between dry needling trigger points and acupuncture treatments in terms of acupoint selection, treatment effects, and potential mechanisms of action, this study seeks to preliminarily explore the feasibility of integrating trigger point theory into the meridian 'acupoint' theory, laying the foundation for a modern interpretation of acupuncture
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Efficacy of Myofascial Trigger Point Dry Needling in Treatment of Primary Dysmenorrhea: A Study Protocol for a Three-Arm Randomized Controlled Trial.
Sun Y, Yang L, Zhu L, Zhang S, et al · · 2025 · PMID 40933501 · DOI 10.2147/jpr.s537971
Verify or expand the search:
- PubMed search for NCT06316583
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Trigger Point Pain, Myofascial
Currently open trials in the same condition.
- NCT07138807 — Effect of MET vs Neck Calliet Exercises on Neck Pain and Disability in Nurses · NA · recruiting
- NCT06986707 — Strain Counterstrain Technique and Graston Technqiue on Quadratus Lumborum Trigger Points · NA · recruiting
- NCT06986317 — Effectiveness of Positional Release Techniques and Graston Technique In Trigger Point · NA · recruiting
- NCT06664359 — Safe Zone in Trigger Point Injection · recruiting
- NCT05793086 — Evaluation of a Novel Class of Objective Myofascial Pain Assessments · active not recruiting
Other Beijing Hospital trials
Trials by the same sponsor.
- NCT07523724 — Screening and Management of Adults With Asthma and Allergic Diseases · NA · not yet recruiting
- NCT07398430 — Metabolic Characteristics and Prognostic Model of Acute Coronary Syndrome Complicated With Obstructive Sleep Apnea · not yet recruiting
- NCT07295665 — External Validation of Ischemia and Hemorrhage Risk Models in Patients With Coronary Heart Disease · not yet recruiting
- NCT07143851 — Multi-modal Intelligent Diagnosis System for Multiple Ophthalmic Diseases · not yet recruiting
- NCT06955819 — GUTPROH: Probiotic-Herbal Formula for Self-Reported Constipation in Community Adults · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06316583 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Beijing Hospital
- Last refreshed: 21 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06316583.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing